tiprankstipranks
Trending News
More News >
Albaad Massuot Yitzhak Ltd. (IL:ALBA)
:ALBA
Israel Market
Advertisement

Albaad (ALBA) AI Stock Analysis

Compare
0 Followers

Top Page

IL:ALBA

Albaad

(ALBA)

Select Model
Select Model
Select Model
Outperform 74 (OpenAI - 4o)
Rating:74Outperform
Price Target:
3,315.00
▲(10.50% Upside)
Albaad's stock is supported by strong technical indicators and an attractive valuation, suggesting potential for growth. However, financial performance is mixed due to high leverage and declining cash flow, which are risks to monitor.
Positive Factors
Revenue Growth
Strong revenue growth indicates successful market expansion and product demand, supporting long-term business sustainability.
Profitability Improvement
Improved profitability enhances shareholder value and provides resources for reinvestment and growth.
Sustainability Initiatives
Sustainability efforts can lead to cost efficiencies and appeal to a growing segment of eco-conscious consumers, strengthening market position.
Negative Factors
High Leverage
High leverage can increase financial risk and limit flexibility, potentially impacting long-term financial health and growth capacity.
Declining Cash Flow
Declining cash flow growth reduces the company's ability to fund operations and investments, posing a risk to financial stability.
Operational Efficiency
Moderate margins suggest potential inefficiencies; improving these could enhance profitability and competitiveness.

Albaad (ALBA) vs. iShares MSCI Israel ETF (EIS)

Albaad Business Overview & Revenue Model

Company DescriptionAlbaad Massuot Yitzhak Ltd produces and sells wipes worldwide. It offers cleaning hand wipes including disinfecting and antibacterial wipes; cosmetic wipes, such as facial care, body, and feet care wipes; feminine hygienic product, which include tampons; and baby, maternity, toddler, and household cleaning wipes. The company also provides professional wipes, such as para-medical, veterinary, automotive, and restaurant wipes, as well as sachets; adult wipes including adult bed and bath; personal care wipes, which include intimate wipes; para-pharma wipes and flushable moist toilet paper product. In addition, it offers contract, private label, and institutional manufacturing services. The company was founded in 1985 and is based in Nir Yitzhak, Israel.
How the Company Makes MoneyAlbaad generates revenue through multiple key streams, primarily by manufacturing and selling nonwoven fabric hygiene products to various retailers, wholesalers, and distributors. The company benefits from long-term contracts with major brands, ensuring a steady flow of income. Additionally, Albaad invests in research and development to create innovative products that cater to changing consumer preferences, which allows them to maintain a competitive edge. Partnerships with leading companies in the personal care industry further enhance their market reach and profitability. The company also focuses on sustainability initiatives, which not only attract environmentally-conscious consumers but may provide cost savings in production, contributing positively to their earnings.

Albaad Financial Statement Overview

Summary
Albaad shows positive revenue growth and improved profitability metrics. However, high leverage and declining free cash flow growth present risks. Operational efficiency and debt management are areas for improvement.
Income Statement
75
Positive
Albaad's income statement shows a positive trajectory with a significant revenue growth rate of 29.3% in the TTM period. The gross profit margin is stable at around 20%, and the net profit margin has improved to 2.93% from previous negative figures. However, the EBIT and EBITDA margins are moderate, indicating room for operational efficiency improvements.
Balance Sheet
65
Positive
The balance sheet reveals a high debt-to-equity ratio of 1.49, indicating significant leverage, although it has improved from previous years. The return on equity has increased to 11.44%, reflecting better profitability. The equity ratio remains stable, suggesting a balanced asset structure, but the high leverage poses potential risks.
Cash Flow
60
Neutral
Cash flow analysis shows a decline in free cash flow growth by 20.29% in the TTM period, which is concerning. The operating cash flow to net income ratio is low at 0.22, indicating limited cash conversion efficiency. However, the free cash flow to net income ratio of 0.61 suggests some level of cash generation capability.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.75B1.72B1.71B1.45B1.49B1.58B
Gross Profit347.92M347.93M344.37M235.00M270.70M418.70M
EBITDA199.50M192.42M176.03M78.18M192.56M281.40M
Net Income51.23M44.88M30.23M-35.12M-20.34M101.31M
Balance Sheet
Total Assets1.54B1.51B1.58B1.60B1.57B1.41B
Cash, Cash Equivalents and Short-Term Investments9.41M25.16M19.13M27.19M18.24M34.05M
Total Debt698.72M712.92M829.03M836.53M802.11M609.00M
Total Liabilities1.06B1.07B1.18B1.24B1.14B927.61M
Stockholders Equity470.31M426.68M394.08M346.83M430.25M478.58M
Cash Flow
Free Cash Flow85.53M101.60M120.98M-67.58M-38.08M114.28M
Operating Cash Flow139.84M152.50M233.23M18.57M52.58M184.72M
Investing Cash Flow-14.56M-9.51M-110.94M-30.36M-170.24M-22.61M
Financing Cash Flow-137.09M-135.56M-134.49M20.46M103.68M-149.09M

Albaad Technical Analysis

Technical Analysis Sentiment
Positive
Last Price3000.00
Price Trends
50DMA
2661.66
Positive
100DMA
2430.13
Positive
200DMA
2115.02
Positive
Market Momentum
MACD
103.73
Negative
RSI
63.05
Neutral
STOCH
61.19
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:ALBA, the sentiment is Positive. The current price of 3000 is above the 20-day moving average (MA) of 2753.75, above the 50-day MA of 2661.66, and above the 200-day MA of 2115.02, indicating a bullish trend. The MACD of 103.73 indicates Negative momentum. The RSI at 63.05 is Neutral, neither overbought nor oversold. The STOCH value of 61.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:ALBA.

Albaad Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
488.01M9.533.65%1.75%5.26%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:ALBA
Albaad
3,000.00
1,190.87
65.83%
IL:SANO1
Sano
39,850.00
5,046.54
14.50%
IL:AMRK
Amir Mark.
3,425.00
600.39
21.26%
IL:AVIV
Aviv
2,007.00
43.91
2.24%
IL:OVRS
Overseas
539.10
169.21
45.75%
IL:LSCO
Lesico
391.20
14.35
3.81%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 21, 2025